BACKGROUND: Extremely low gestational age newborns (ELGANs) are at increased risk for structural and functional brain abnormalities. AIM: To identify factors that contribute to brain damage in ELGANs. STUDY DESIGN: Multi-center cohort study. SUBJECTS: We enrolled 1506 ELGANs born before 28 weeks gestation at 14 sites; 1201 (80%) survived to 2 years corrected age. Information about exposures and characteristics was collected by maternal interview, from chart review, microbiologic and histological examination of placentas, and measurement of proteins in umbilical cord and early postnatal blood spots. OUTCOME MEASURES: Indicators of white matter damage, i.e. ventriculomegaly and echolucent lesions, on protocol cranial ultrasound scans; head circumference and developmental outcomes at 24 months adjusted age, i.e., cerebral palsy, mental and motor scales of the Bayley Scales of Infant Development, and a screen for autism spectrum disorders. RESULTS: ELGAN Study publications thus far provide evidence that the following are associated with ultrasongraphically detected white matter damage, cerebral palsy, or both: preterm delivery attributed to preterm labor, prelabor premature rupture of membranes, or cervical insufficiency; recovery of microorganisms in the placenta parenchyma, including species categorized as human skin microflora; histological evidence of placental inflammation; lower gestational age at delivery; greater neonatal illness severity; severe chronic lung disease; neonatal bacteremia; and necrotizing enterocolitis. CONCLUSIONS: In addition to supporting a potential role for many previously identified antecedents of brain damage in ELGANs, our study is the first to provide strong evidence that brain damage in extremely preterm infants is associated with microorganisms in placenta parenchyma.
BACKGROUND: Extremely low gestational age newborns (ELGANs) are at increased risk for structural and functional brain abnormalities. AIM: To identify factors that contribute to brain damage in ELGANs. STUDY DESIGN: Multi-center cohort study. SUBJECTS: We enrolled 1506 ELGANs born before 28 weeks gestation at 14 sites; 1201 (80%) survived to 2 years corrected age. Information about exposures and characteristics was collected by maternal interview, from chart review, microbiologic and histological examination of placentas, and measurement of proteins in umbilical cord and early postnatal blood spots. OUTCOME MEASURES: Indicators of white matter damage, i.e. ventriculomegaly and echolucent lesions, on protocol cranial ultrasound scans; head circumference and developmental outcomes at 24 months adjusted age, i.e., cerebral palsy, mental and motor scales of the Bayley Scales of Infant Development, and a screen for autism spectrum disorders. RESULTS:ELGAN Study publications thus far provide evidence that the following are associated with ultrasongraphically detected white matter damage, cerebral palsy, or both: preterm delivery attributed to preterm labor, prelabor premature rupture of membranes, or cervical insufficiency; recovery of microorganisms in the placenta parenchyma, including species categorized as human skin microflora; histological evidence of placental inflammation; lower gestational age at delivery; greater neonatal illness severity; severe chronic lung disease; neonatal bacteremia; and necrotizing enterocolitis. CONCLUSIONS: In addition to supporting a potential role for many previously identified antecedents of brain damage in ELGANs, our study is the first to provide strong evidence that brain damage in extremely preterm infants is associated with microorganisms in placenta parenchyma.
Authors: Karl C K Kuban; Michael O'Shea; Elizabeth Allred; Alan Leviton; Herbert Gilmore; Adré DuPlessis; Kalpathy Krishnamoorthy; Cecil Hahn; Janet Soul; Sunila E O'Connor; Karen Miller; Paige T Church; Cecilia Keller; Richard Bream; Robin Adair; Alice Miller; Elaine Romano; Haim Bassan; Kathy Kerkering; Steve Engelke; Diane Marshall; Kristy Milowic; Janice Wereszczak; Carol Hubbard; Lisa Washburn; Robert Dillard; Cherrie Heller; Wendy Burdo-Hartman; Lynn Fagerman; Dinah Sutton; Padu Karna; Nick Olomu; Leslie Caldarelli; Melisa Oca; Kim Lohr; Albert Scheiner Journal: J Child Neurol Date: 2005-10 Impact factor: 1.987
Authors: Richard A Ehrenkranz; Michele C Walsh; Betty R Vohr; Alan H Jobe; Linda L Wright; Avroy A Fanaroff; Lisa A Wrage; Kenneth Poole Journal: Pediatrics Date: 2005-12 Impact factor: 7.124
Authors: Olaf Dammann; Wolfgang Bueter; Alan Leviton; Pierre Gressens; Christiane E L Dammann Journal: Neonatology Date: 2007-11-09 Impact factor: 4.035
Authors: Camilia R Martin; Yolanda F Brown; Richard A Ehrenkranz; T Michael O'Shea; Elizabeth N Allred; Mandy B Belfort; Marie C McCormick; Alan Leviton Journal: Pediatrics Date: 2009-07-27 Impact factor: 7.124
Authors: T F McElrath; J L Hecht; O Dammann; K Boggess; A Onderdonk; G Markenson; M Harper; E Delpapa; E N Allred; A Leviton Journal: Am J Epidemiol Date: 2008-08-27 Impact factor: 4.897
Authors: Sunita Trivedi; Maria Joachim; Thomas McElrath; Harvey J Kliman; Elizabeth N Allred; Raina N Fichorova; Andrew Onderdonk; Fernanda Heitor; Leila Chaychi; Alan Leviton; Joseph A Majzoub Journal: Am J Obstet Gynecol Date: 2011-12-16 Impact factor: 8.661
Authors: Yael Dvir; Jean A Frazier; Robert M Joseph; Irina Mokrova; Phoebe S Moore; T Michael OʼShea; Stephen R Hooper; Hudson P Santos; Karl Kuban Journal: J Dev Behav Pediatr Date: 2019-12 Impact factor: 2.225
Authors: T Michael O'Shea; Elizabeth N Allred; Karl C K Kuban; Olaf Dammann; Nigel Paneth; Raina Fichorova; Deborah Hirtz; Alan Leviton Journal: J Pediatr Date: 2011-10-13 Impact factor: 4.406
Authors: Jennifer A Pinto-Martin; Susan E Levy; Judith F Feldman; John M Lorenz; Nigel Paneth; Agnes H Whitaker Journal: Pediatrics Date: 2011-10-17 Impact factor: 7.124
Authors: Elizabeth N Allred; Olaf Dammann; Raina N Fichorova; Stephen R Hooper; Scott J Hunter; Robert M Joseph; Karl Kuban; Alan Leviton; Thomas Michael O'Shea; Megan N Scott Journal: J Neuroimmune Pharmacol Date: 2017-04-12 Impact factor: 4.147
Authors: Sabrina Salberg; Glenn R Yamakawa; Yannick Griep; Jesse Bain; Jaimie K Beveridge; Mujun Sun; Stuart J McDonald; Sandy R Shultz; Rhys D Brady; David K Wright; Melanie Noel; Richelle Mychasiuk Journal: Cereb Cortex Commun Date: 2021-02-24
Authors: Anuradha Phadke; Michael E Msall; Patrick Droste; Elizabeth N Allred; Thomas Michael O'Shea; Karl Kuban; Olaf Dammann; Alan Leviton Journal: Pediatr Neurol Date: 2014-03-15 Impact factor: 3.372